Literature DB >> 30299220

Achieving high HPV vaccine completion rates in a pediatric clinic population.

Abbey B Berenson1, Richard Rupp1, Erin E Dinehart1,2, Leslie E Cofie1,3, Yong-Fang Kuo, Jacqueline M Hirth1.   

Abstract

Objective: To evaluate the efficacy of an intervention utilizing patient navigators (PNs) to 1) educate families on human papillomavirus (HPV) vaccination in a clinic setting and 2) provide personalized reminders for follow-up. Method: Families with 9-17 year-old children who had no record of completing the HPV vaccination series receiving primary or specialty care in 3 pediatric clinics were approached by PNs between February 1, 2015 and August 31, 2016. Demographic characteristics, visit type, preferred contact method, rates and correlates of completion, and appointments missed were analyzed. In addition, qualitative interviews of 21 providers and PNs assessed their perceptions of the program.
Results: 1,391 adolescents were identified out of 2,162 patients approached as unvaccinated or partially vaccinated prior starters; among the unvaccinated, 930 received the 1st dose after being counseled by the PN (66.9%), either immediately or at a follow-up visit soon thereafter. This included 118 siblings of patients who did not have an appointment that day. Of initiators approached between 2/1/2015 and 8/31/2016, 93% (864/930) completed the series by 8/31/2017. No differences in series completion among initiators were observed by gender or race/ethnicity, but older patients (15-17 years old) were less likely to complete than 11-12 year olds. Of the 688 patients identified as prior starters, 85% completed the series through the program. Qualitative interviews demonstrated that providers felt the program addressed major barriers to HPV vaccination.
Conclusion: Employing PNs dramatically increased HPV vaccine series completion among boys and girls with historically low HPV vaccination rates at pediatric clinics in Texas. Clinic providers felt this program addressed many barriers they observed prior to program implementation. This approach could markedly improve HPV vaccine series completion rates in the US.

Entities:  

Keywords:  Cancer prevention; HPV vaccine; Human papillomavirus (HPV); intervention; patient navigation

Mesh:

Substances:

Year:  2018        PMID: 30299220      PMCID: PMC6746521          DOI: 10.1080/21645515.2018.1533778

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  31 in total

1.  The architecture of provider-parent vaccine discussions at health supervision visits.

Authors:  Douglas J Opel; John Heritage; James A Taylor; Rita Mangione-Smith; Halle Showalter Salas; Victoria Devere; Chuan Zhou; Jeffrey D Robinson
Journal:  Pediatrics       Date:  2013-11-04       Impact factor: 7.124

2.  Racial/Ethnic, socioeconomic, and geographic disparities of cervical cancer advanced-stage diagnosis in Texas.

Authors:  F Benjamin Zhan; Yan Lin
Journal:  Womens Health Issues       Date:  2014-08-12

3.  A brief educational intervention increases providers' human papillomavirus vaccine knowledge.

Authors:  Abbey B Berenson; Mahbubur Rahman; Jacqueline M Hirth; Richard E Rupp; Kwabena O Sarpong
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  The effectiveness of patient navigation to improve healthcare utilization outcomes: A meta-analysis of randomized controlled trials.

Authors:  Sobia F Ali-Faisal; Tracey J F Colella; Naomi Medina-Jaudes; Lisa Benz Scott
Journal:  Patient Educ Couns       Date:  2016-10-17

5.  A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

Authors:  Elmar A Joura; Anna R Giuliano; Ole-Erik Iversen; Celine Bouchard; Constance Mao; Jesper Mehlsen; Edson D Moreira; Yuen Ngan; Lone Kjeld Petersen; Eduardo Lazcano-Ponce; Punnee Pitisuttithum; Jaime Alberto Restrepo; Gavin Stuart; Linn Woelber; Yuh Cheng Yang; Jack Cuzick; Suzanne M Garland; Warner Huh; Susanne K Kjaer; Oliver M Bautista; Ivan S F Chan; Joshua Chen; Richard Gesser; Erin Moeller; Michael Ritter; Scott Vuocolo; Alain Luxembourg
Journal:  N Engl J Med       Date:  2015-02-19       Impact factor: 91.245

6.  Relationship between maternal experiences and adolescent HPV vaccination.

Authors:  Abbey B Berenson; V Gnaukita Brown; Erika L Fuchs; Jacqueline M Hirth; Mihyun Chang
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

7.  Why don't adolescents finish the HPV vaccine series? A qualitative study of parents and providers.

Authors:  Rebecca B Perkins; Nagasudha L Chigurupati; Gauri Apte; Jessica Vercruysse; Constance Wall-Haas; Anna Rosenquist; Laura Lee; Jack A Clark; Natalie Pierre-Joseph
Journal:  Hum Vaccin Immunother       Date:  2016-01-25       Impact factor: 3.452

8.  Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.

Authors:  Ahmedin Jemal; Edgar P Simard; Christina Dorell; Anne-Michelle Noone; Lauri E Markowitz; Betsy Kohler; Christie Eheman; Mona Saraiya; Priti Bandi; Debbie Saslow; Kathleen A Cronin; Meg Watson; Mark Schiffman; S Jane Henley; Maria J Schymura; Robert N Anderson; David Yankey; Brenda K Edwards
Journal:  J Natl Cancer Inst       Date:  2013-01-07       Impact factor: 13.506

9.  Factors Associated With Parents' Intent to Vaccinate Adolescents for Human Papillomavirus: Findings From the 2014 National Immunization Survey-Teen.

Authors:  Kahee A Mohammed; Elaina Vivian; Travis M Loux; Lauren D Arnold
Journal:  Prev Chronic Dis       Date:  2017-06-08       Impact factor: 2.830

10.  Factors associated with parental reasons for "no-intent" to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008-2012.

Authors:  Vinay K Cheruvu; Madhav P Bhatta; Lauren N Drinkard
Journal:  BMC Pediatr       Date:  2017-02-13       Impact factor: 2.125

View more
  6 in total

1.  Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer.

Authors:  Sharon M Castellino; Kristen E Allen; Katherine Pleasant; Graham Keyes; Katherine A Poehling; Janet A Tooze
Journal:  J Cancer Surviv       Date:  2019-07-24       Impact factor: 4.442

2.  Caregiver acceptance of a patient navigation program to increase human papillomavirus vaccination in pediatric clinics: a qualitative program evaluation.

Authors:  Jacqueline M Hirth; Abbey B Berenson; Leslie E Cofie; Lena Matsushita; Yong-Fang Kuo; Richard E Rupp
Journal:  Hum Vaccin Immunother       Date:  2019-04-04       Impact factor: 3.452

3.  Factors associated with HPV vaccination initiation among United States college students.

Authors:  Lane McLendon; Jesse Puckett; Chelsea Green; Jenna James; Katharine J Head; Hee Yun Lee; Jennifer Young Pierce; Mark Beasley; Casey L Daniel
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

Review 4.  There's Much Yet to be Done: Diverse Perspectives on HPV Vaccination.

Authors:  Gregory D Zimet; Nosayaba Osazuwa-Peters
Journal:  Hum Vaccin Immunother       Date:  2019       Impact factor: 3.452

5.  Human papillomavirus dose reminder preferences among parents from a diverse clinical sample: a qualitative study.

Authors:  Jacqueline M Hirth; Kayla A Eboreime; Leslie E Cofie; Richard E Rupp; Abbey B Berenson
Journal:  Hum Vaccin Immunother       Date:  2022-02-18       Impact factor: 3.452

6.  A Real-world Claims Data Analysis of Meningococcal Serogroup B Vaccine Series Completion and Potential Missed Opportunities in the United States.

Authors:  Elizabeth R Packnett; Nicole M Zimmerman; Gilwan Kim; Patricia Novy; Laura C Morgan; Nnenna Chime; Parinaz Ghaswalla
Journal:  Pediatr Infect Dis J       Date:  2022-04-01       Impact factor: 3.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.